Following on from our original notification of the 1 March 2019 and subsequent notification of 13 March 2019 relating to the above mentioned subject, we provided further and hopefully final information.

The Ministry of Health have reclassified a specific range of medications to Restricted Medicines (Pharmacist Only), and in one specific case to Prescription Only.

We urge you to double check that all stock affected by this reclassification has been moved to the Restricted Medicines area and in the case of Gee’s Linctus to the Dispensary only. The reason we raise this is that we found stock on a pharmacy shelf last weekend.  If there was a spot Audit the outcome could have been a lot different.

Click here to access a listing of products that are affected by the reclassification. This listing is from the previous Medsafe document and may not list all affected products.

Click here to access the Pfizer information provided to pharmacy.

Two major changes have occurred since the original information was advised relating to the extension of the transition periods for all affected products.

1 – Manufacturers will cease supplying wholesalers with old packaging for the effected products by 25 August 2019.

2 – Pharmacists must cease selling the affected old packaging by 25 February 2020.

Given that we are now in Autumn and heading into Winter, Pharmacy should clearly be in a position to sell all existing stock of the listed products, albeit under the Pharmacist Only criteria, in all cases except Gee’s Linctus which goes directly to Prescription Only.

Therefore we are unable to accept any of the products involved in this reclassification for credit including Gee’s Linctus 200 ml or 2L. Please do not return stock as a refusal may offend and that is not our intention.

If you have not moved your stock of the products  containing Dextromethorphan from the shelves and put into the Pharmacist Only area, away from the public then we strongly suggest you do so immediately.

Gee’s Linctus must be moved to the Dispensary as the reclassification clearly determined that it is now a prescription only product.

API have today (6 March 2019) advised that they will DISCONTINUE Gees Linctus 200 ml and Opiate Squill Linctus 2L effective 25 August 2019 (you can continue dispense the current product until 25 February 2020)

Wholesalers therefore will manage stock accordingly as we must sell through all current Pharmacy Only labelled stock no later than 25 August 2019.

API has communicated the change in classification to GP’s to ensure they are aware of the need to now write a prescription for Gee’s Linctus. This will assist pharmacy to move through their existing stocks.

Click here to read the API notification to GP’s – feel free to pass this on to your GP practices in your area.

ProPharma / PWR are working with API to discuss terms of returns of excess stock and further details will be provided in due course.

Finally, a reminder that you can sell all of the products containing Dextromethorpan with current Pharmacy Medicine labelling, under the Pharmacist Only criteria until 25 February 2020.

You can also dispense Gee’s Linctus with the Pharmacy Medicine labelling until 25 February 2020.

Please refer to the below website.

https://gazette.govt.nz/notice/id/2019-go841?fbclid=IwAR2SfGmiFLOOekdd5DyrviNsBH6gxUEEf7Cgnljszl2p0ZC8MF3g9opVQRo

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author

Close